Researchers ID a Potential Biomarker for CSU Treatment Response
New research links a rare form of mast cells to chronic spontaneous urticaria (CSU) treatment response. Researchers compared myeloid progenitors in blood of with CSU and healthy controls. Treatment response to the anti-IgE therapy omalizumab (Xolair, Novartis and Genentech) was also assessed. Individuals who had a fast response to omalizumab were found to have higher numbers of myeloid […]